Sort   by:  
 Page size 
UnknownEpidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France.
Not available
S-EPMC7455315 | biostudies-literature
UnknownCSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis.
Not available
S-EPMC4630685 | biostudies-literature
UnknownThe influence of age categories on performance parameters during on-court testing in wheelchair basketball players.
Not available
S-EPMC12316469 | biostudies-literature
ModelsRibba2012 - Low-grade gliomas, tumour growth inhibition model
Ribba2012 - Low-grade gliomas, tumour growth inhibition model Using longitudinal mean tumour diameter (MTD) data, this model describe the size evolution of low-grade glioma (LGG) in patients treated with chemotherapy or radiotherapy. This model is...
2024-09-02 | BIOMD0000000521 | BioModels
UnknownSystematic Review of Immune and Symptomatic Treatments for Stiff-Person Syndrome.
Not available
S-EPMC12639332 | biostudies-literature
UnknownIncreasing the Time Interval between PCV Chemotherapy Cycles as a Strategy to Improve Duration of Response in Low-Grade Gliomas: Results from a Model-Based Clinical Trial Simulation.
Not available
S-EPMC4693002 | biostudies-literature
UnknownAnti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications.
Not available
S-EPMC3002663 | biostudies-literature
UnknownCSF HIV RNA Escape in Opsoclonus-Myoclonus-Ataxia Syndrome: Case Report and Review of the Literature.
Not available
S-EPMC7719769 | biostudies-literature
UnknownSuccessful Management of Anti-mGluR1 Encephalitis with Immunosuppressive Treatment: Dengue Virus as a Trigger?
Not available
S-EPMC6856456 | biostudies-literature
UnknownTumor Treating Fields (TTFields) therapy vs physicians' choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19).
Not available
S-EPMC9568629 | biostudies-literature
Sort   by:  
 Page size